Us Colorectal Cancer Diagnostics Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Colorectal Cancer Diagnostics Market was valued at USD 6.75 Billion in 2022 and is projected to reach USD 10.21 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The US colorectal cancer diagnostics market is witnessing a significant transformation, driven by advancements in technology and a growing emphasis on early detection. As the second leading cause of cancer deaths in the US, colorectal cancer’s early diagnosis is crucial, and the market is responding with innovative solutions.
Currently valued at approximately $2.5 billion, the market is projected to grow at a compound annual growth rate (CAGR) of 8.5% through 2028. This growth is largely attributed to increasing awareness of colorectal cancer screening and the integration of advanced diagnostic techniques. Innovations such as liquid biopsy, artificial intelligence (AI), and next-generation sequencing are reshaping the landscape of diagnostics, making tests more accessible and accurate.
Among the various diagnostic methods, colonoscopy remains the gold standard, but there are emerging non-invasive options like stool DNA tests gaining traction. These tests not only offer comfort to patients but also enhance compliance with screening recommendations, crucial for reducing mortality rates. The recent introduction of AI in interpreting colonoscopy images is expected to improve detection rates significantly.
Furthermore, the market is segmented into segments based on technology, including imaging, biopsy, and genetic testing. Genetic testing is particularly noteworthy, as it allows for personalized treatment plans and informs patients about hereditary cancer risks. As patient-centric care becomes a priority, these technologies are essential for effective management.
As the US healthcare system continues to emphasize value-based care, the colorectal cancer diagnostics market is poised for sustained growth. With a strong focus on early detection and innovative technologies, patients can expect more effective and less invasive diagnostic options. Engaging with the market's developments not only highlights its importance but also serves as a reminder of the ongoing battle against colorectal cancer.
Get an In-Depth Research Analysis of the Global Colorectal Cancer Diagnostics Market Size And Forecast [2025-2032]
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Colorectal Cancer Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Colorectal Cancer Diagnostics Market
Colonoscopy
Stool-based Tests
Biopsy
Imaging Techniques
Hospitals
Diagnostic Laboratories
Specialty Clinics
Screening Tests
Diagnostic Tests
Monitoring Tests
Molecular Diagnostics
Immunohistochemistry
Next-Generation Sequencing (NGS)
Liquid Biopsy
Age
Gender
Genetic Predisposition
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Colorectal Cancer Diagnostics Market Research Analysis
1. Introduction of the Global Colorectal Cancer Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Colorectal Cancer Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Colorectal Cancer Diagnostics Market, By Type
6. Global Colorectal Cancer Diagnostics Market, By Application
7. Global Colorectal Cancer Diagnostics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Colorectal Cancer Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/